Wikidata

(Q64150362)

English

A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis

clinical trial

In more languages

Statements

short name
MOSAIC (English)
0 references
title
A PHASE 4, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE IMPACT OF APREMILAST (CC-10004) MONOTHERAPY ON MRI OUTCOMES IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS (English)
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
Denmark
0 references
Germany
0 references
Italy
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
29 January 2019
0 references
end time
11 November 2020
0 references
number of participants
120
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64150362&oldid=1857570699"